TrialCancer medicine2019
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
Eudocia Q Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it
TrialCancer medicine2019
Eudocia Q Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.